✦ LIBER ✦

Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study

✍ Scribed by KB Sims; GM Pastores; NJ Weinreb; J Barranger; BE Rosenbloom; S Packman; P Kaplan; H Mankin; R Xavier; J Angell; MA Fitzpatrick; D Rosenthal

Book ID: 110888575
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 207 KB
Volume: 73
Category: Article
ISSN: 0009-9163
DOI: 10.1111/j.1399-0004.2008.00978.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized trial comparing the efficac

A randomized trial comparing the efficacy and safety of imiglucerase (Cerezyme) infusions every 4 weeks versus every 2 weeks in the maintenance therapy of adult patients with Gaucher disease type 1

✍ P.S. Kishnani; M. DiRocco; P. Kaplan; A. Mehta; G.M. Pastores; S.E. Smith; A.C. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 241 KB

A phase 3, randomized, double-blind, pla

A phase 3, randomized, double-blind, placebo-controlled, multi-center study to investigate the efficacy and safety of eliglustat in patients with Gaucher disease type 1 (ENGAGE): Results after 9months of treatment

✍ Mistry, Pramod; Lukina, Elena; Dridi, Marie-Françoise Ben; Amato, Dominick; Bari 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 77 KB